Biological and genetic determinants of serum apoC-III concentration: reference limits from the Stanislas Cohort

J Lipid Res. 2003 Feb;44(2):430-6. doi: 10.1194/jlr.M200006-JLR200. Epub 2002 Oct 1.

Abstract

Apolipoprotein C-III (apoC-III) is involved in triglycerides metabolism, and is therefore important for the pathogenesis of coronary heart diseases. However, to our knowledge serum apoC-III variation factors and reference limits have never been determined, so the aim of this study was to establish them and facilitate clinical usefulness. We measured serum apoC-III concentration of apparently healthy subjects of the Stanislas Cohort by an immunoturbidimetric method. Genetic polymorphisms within the APOC3, APOE, APOAIV, and LPL genes were determined by a multiplex PCR. Serum apoC-III concentration varied from 28.2 mg/l to 225.8 mg/l in the overall sample and between subjects variability was about 30%. Factors influencing apoC-III concentration were age, BMI in adult men, alcohol consumption in adults, oral contraceptive intake in women, the post-pubescent status in boys. The APOC3 1100T allele in adult men and the APOC3 -455C allele in boys were associated with increased apoC-III concentration. The APOA4 360His allele was associated with decreased apoC-III concentration in women. We also established reference limits of serum apoC-III concentration according to age and gender.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Apolipoprotein C-III
  • Apolipoproteins C / blood*
  • Apolipoproteins C / genetics*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • France
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Genetic
  • Reference Values

Substances

  • Apolipoprotein C-III
  • Apolipoproteins C